OverviewSuggest Edit

Novozymes is a company that specializes in the production and distribution of industrial enzymes and microorganisms. It focuses on a range of industry sectors, including food and beverages, bioenergy, agriculture, pharma, household care, etc. The company aims to promote sustainability, achieve more efficient use of raw materials, and reduce energy consumption.
TypePublic
Founded2000
HQBagsværd, DK
Websitenovozymes.com
Employee Ratings3.9

Latest Updates

Employees (est.) (Sept 2020)6,180(+2%)
Job Openings60
Revenue (FY, 2019)KR14.4 B
Share Price (Jun 2021)KR449.1
Cybersecurity ratingBMore

Key People/Management at Novozymes

Ester Baiget

Ester Baiget

President and CEO
Lars Green

Lars Green

Executive Vice President and CFO
Tina Fano

Tina Fano

Executive Vice President, Agriculture & Industrial Biosolutions
Andrew Fordyce

Andrew Fordyce

Executive Vice President, Food & Beverages
Agnete Raaschou-Nielsen

Agnete Raaschou-Nielsen

Vice Chairman
Prisca Havranek-Kosicek

Prisca Havranek-Kosicek

CFO & Executive Vice President, Corporate Functions
Show more

Novozymes Office Locations

Novozymes has offices in Bagsværd, Kalundborg, Ames, Blair and in 32 other locations
Bagsværd, DK (HQ)
36 Krogshøjvej
Kalundborg, DK
Hallas Alle 1
Buenos Aires, AR
Rua 10 Nº 753, B1629 MXA
North Rocks, AU
3/22 Loyalty Rd
Barigui, BR
R. Prof. Francisco Ribeiro, 683
Quatro Barras, BR
R. Aristeu Luciano Adamoski, 12 - Jardim Menino Deus
Show all (37)

Novozymes Financials and Metrics

Novozymes Revenue

Embed Graph
View revenue for all periods
Novozymes's revenue was reported to be kr14.37 b in FY, 2019 which is a 0.1% decrease from the previous period.
DKK

Revenue (Q3, 2020)

3.4b

Gross profit (Q3, 2020)

1.9b

Gross profit margin (Q3, 2020), %

56.1%

Net income (Q3, 2020)

711.0m

EBITDA (Q3, 2020)

1.2b

EBIT (Q3, 2020)

894.0m

Market capitalization (4-Jun-2021)

250.5b

Closing stock price (4-Jun-2021)

449.1

Cash (30-Sept-2020)

856.0m

EV

255.1b
Novozymes's current market capitalization is kr250.5 b.
Annual
DKKFY, 2017FY, 2018FY, 2019

Revenue

14.5b14.4b14.4b

Revenue growth, %

3%(1%)0%

Cost of goods sold

6.1b6.1b6.4b

Gross profit

8.4b8.3b8.0b
Quarterly
DKKQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

3.5b3.5b3.7b3.5b3.5b3.7b3.8b3.3b3.4b

Cost of goods sold

1.5b1.5b1.5b1.5b1.6b1.6b1.6b1.5b1.5b

Gross profit

2.0b2.0b2.1b1.9b1.9b2.1b2.2b1.9b1.9b

Gross profit Margin, %

58%57%58%56%55%56%57%55%56%
Annual
DKKFY, 2017FY, 2018FY, 2019

Cash

632.0m723.0m711.0m

Accounts Receivable

2.6b2.6b2.9b

Inventories

2.6b2.8b2.6b

Current Assets

6.1b6.8b7.1b
Quarterly
DKKQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

716.0m501.0m582.0m727.0m910.0m651.0m926.0m1.0b856.0m

Accounts Receivable

2.5b2.5b2.6b2.5b2.5b2.7b2.9b2.7b2.7b

Inventories

2.6b2.8b2.8b2.8b2.8b2.8b2.6b2.6b2.5b

Current Assets

6.5b6.4b6.7b6.8b6.8b6.8b7.2b6.9b6.6b
Annual
DKKFY, 2017FY, 2018FY, 2019

Net Income

3.1b3.2b3.2b

Depreciation and Amortization

1.1b1.1b1.2b

Inventories

(224.0m)(234.0m)218.0m

Accounts Payable

74.0m(265.0m)(124.0m)
Quarterly
DKKQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

807.0m1.6b2.4b697.0m1.6b2.2b815.0m1.5b2.2b

Inventories

(60.0m)(168.0m)(247.0m)32.0m47.0m42.0m40.0m(37.0m)33.0m

Accounts Payable

(116.0m)(328.0m)(165.0m)(287.0m)(233.0m)(3.0m)(203.0m)(129.0m)(330.0m)

Cash From Operating Activities

684.0m1.5b2.9b563.0m1.6b2.6b963.0m2.4b3.3b
DKKFY, 2017

EV/EBITDA

3.5 x

EV/EBIT

4.4 x

EV/CFO

4.4 x

Revenue/Employee

2.3m

Debt/Equity

0.2 x

Debt/Assets

0.1 x

Financial Leverage

1.6 x

P/E Ratio

5.2
Show all financial metrics

Novozymes Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019

Learners

106 k188 k302 k329 k

New Products

8889

Patents Families

1.12 k1.05 k1.04 k951

Patents and Patent Applications

6.5 k6.5 k6.5 k6.5 k
Show all operating metrics

Novozymes Acquisitions / Subsidiaries

Company NameDateDeal Size
PrecisionBiotics Group LimitedJune 25, 2020kr20 m
OrganoBalance GmbHSeptember 15, 2016kr178 m
Pacific Vet Group-USAOctober 05, 2015
AllopartisOctober 11, 2013
TJ TechnologiesJune 25, 2013
Iogen Bio-ProductsFebruary 01, 2013
Natural IndustriesNovember 28, 2012
Turfal Indústria e Comércio de Produtos Agrônomicos e BiológicosAugust 08, 2010
Philom BiosOctober 31, 2007
Earth BioSciencesOctober 02, 2006
Show more

Novozymes Revenue Breakdown

Embed Graph

Novozymes revenue breakdown by business segment: 29.0% from Food and Beverages, 19.6% from Bioenergy, 13.1% from Agriculture and Feed, 5.2% from Technical and Pharma and 33.1% from Household Care

Novozymes revenue breakdown by geographic segment: 36.0% from Rest of Europe, Middle East and Africa, 33.0% from North America, 9.8% from Latin America, 20.0% from Asia Pacific and 1.2% from Other

Show all human capital metrics

Novozymes Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Novozymes Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

CSRHub logo

Novozymes Online and Social Media Presence

Embed Graph

Novozymes News and Updates

Worldwide Enzymes Industry to 2027 - Players Include BASF, Associated British Foods and Novozymes Among Others

Dublin, May 27, 2021 (GLOBE NEWSWIRE) -- The "Global Enzymes Market By Source, By Type, By Reaction Type, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering. The Global Enzymes Market size is expected …

Worldwide Agricultural Microbial Industry (2021 to 2026) - Featuring Certis, Novozymes and Dow AgroSciences Among Others

DUBLIN, May 12, 2021 /PRNewswire/ -- The "Agricultural Microbial Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global agricultural microbial market is expected to grow at a compound annual growth rate of 12.61% over the forecast...

Novozymes delivers solid Q1 results with 3% organic sales growth and strong earnings

Novozymes delivered 3% organic sales growth in the first quarter of the 2021 financial year and an EBIT margin of 29.6%. The company maintains its full-year financial guidance.

Novozymes A/S’ Annual Shareholders’ Meeting 2021

Read the full announcement in PDF

Agricultural Microbials Market Size to Hit USD 11.81 Billion by 2027; Syngenta Collaborates Novozymes to Commercialize TAEGRO IN Europe & Latin America, States Fortune Business Insights™

Top companies covered are Certis USA LLC (Columbia, U.S.), Marrone Bio Innovations, Inc. (California, U.S.), ChemChina (Beijing, China), Koppert Biological Systems (Netherlands), Varsha Bioscience and Technology Pvt. Ltd. (Hyderabad, India), BASF SE (Ludwigshafen, Germany), Andermatt Biocontrol AG (…

Election of employee representatives to the Board of Directors of Novozymes A/S

The employees of Novozymes A/S have conducted the election of employee representatives to the Board of Directors.
Show more

Novozymes Frequently Asked Questions

  • When was Novozymes founded?

    Novozymes was founded in 2000.

  • Who are Novozymes key executives?

    Novozymes's key executives are Ester Baiget, Lars Green and Tina Fano.

  • How many employees does Novozymes have?

    Novozymes has 6,180 employees.

  • What is Novozymes revenue?

    Latest Novozymes annual revenue is kr14.4 b.

  • What is Novozymes revenue per employee?

    Latest Novozymes revenue per employee is kr2.3 m.

  • Who are Novozymes competitors?

    Competitors of Novozymes include BBCA Group, Lonza and Element Solutions.

  • Where is Novozymes headquarters?

    Novozymes headquarters is located at 36 Krogshøjvej, Bagsværd.

  • Where are Novozymes offices?

    Novozymes has offices in Bagsværd, Kalundborg, Ames, Blair and in 32 other locations.

  • How many offices does Novozymes have?

    Novozymes has 37 offices.